Skip to content
ppharmaranks
Menu

Best Angiotensin Converting Enzyme Inhibitor for hypertension

Top-rated pick: Lotensin — pharmaranks score 72/100, the highest of the 3 Angiotensin Converting Enzyme Inhibitor drugs used for hypertension, ranked by our independent FDA recall-safety score. Compare them with all treatments for hypertension or the full Angiotensin Converting Enzyme Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 3 angiotensin converting enzyme inhibitor drugs we rate for hypertension, 2 are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for hypertension; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Get treated for hypertension online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

Top angiotensin converting enzyme inhibitor for hypertension: 1. Lotensin · 2. Qbrelis · 3. Quinapril Hydrochloride

Best-rated Angiotensin Converting Enzyme Inhibitor for hypertension, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$2View →
272/100$1View →
3Not yet rated—View →

Full ranking · 3 drugs

Frequently asked

What is the best angiotensin converting enzyme inhibitor for hypertension?
By our independent recall-safety rating — not an efficacy measure — lotensin ranks highest among Angiotensin Converting Enzyme Inhibitor drugs used for hypertension. Always consult a professional.
Which angiotensin converting enzyme inhibitor drugs treat hypertension?
pharmaranks lists 3 Angiotensin Converting Enzyme Inhibitor products used for hypertension, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

Where this ranking comes from

Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.